Captafol
|
CAS
2425-06-1
|
C10H9Cl14NO2S
|
RTECS
GW4900000
|
Synonyms & Trade Names
Captofol; Difolatan®; N-((1,1,2,2-Tetrachloroethyl)thio)-4-cyclohexene-1,2-dicarboximide
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: Ca TWA 0.1 mg/m3 [skin] See Appendix A
|
|
OSHA PEL†: none
|
IDLH
Ca [N.D.]
See: IDLH INDEX
|
Conversion
|
Physical Description
White, crystalline solid with a slight, characteristic pungent odor. [fungicide] [Note: Available commercially as a wettable powder or in liquid form.]
|
MW: 349.1
|
BP: Decomposes
|
MLT: 321°F (Decomposes)
|
Sol: 0.0001%
|
VP: 0.000008 mmHg
|
IP: NA
|
Sp.Gr: ?
|
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Solid, but may be dissolved in flammable liquids.
|
Incompatibilities & Reactivities
Acids, acid vapors, strong oxidizers
|
Measurement Methods
NIOSH 0500
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin, respiratory system; dermatitis, skin sensitization; conjunctivitis; bronchitis, wheezing; diarrhea, vomiting; liver, kidney injury; high blood pressure; in animals: teratogenic effects; [potential occupational carcinogen]
|
Target Organs
Eyes, skin, respiratory system, central nervous system, liver, kidneys, cardiovascular system
Cancer Site
[in animals: tumors at many sites]
|
|
See also: INTRODUCTION
See ICSC CARD: 0119 |
